His primary scientific interests are in Microbiology, Antibacterial agent, Antibiotics, Clindamycin and Anaerobic bacteria. His study on Microbiology is mostly dedicated to connecting different topics, such as Virology. His research in Antibacterial agent intersects with topics in Pharmacokinetics, Surgery, Macrolide Antibiotics, Saliva and Linezolid.
His Antibiotics study incorporates themes from Microbiome and Oral administration. His Clindamycin study integrates concerns from other disciplines, such as Diarrhea and Bacteroides fragilis. His research integrates issues of Ecology, Amoxicillin, Bacteroides, Clostridia and Anaerobic exercise in his study of Anaerobic bacteria.
His main research concerns Microbiology, Antibiotics, Anaerobic bacteria, Internal medicine and Antibacterial agent. His Microbiology research incorporates elements of Anaerobic exercise and Bacteroides. His Antibiotics research is multidisciplinary, relying on both Feces and Chemotherapy.
His studies in Anaerobic bacteria integrate themes in fields like Amoxicillin and Clostridium perfringens. Carl Erik Nord has researched Internal medicine in several fields, including Gastroenterology and Surgery. His biological study spans a wide range of topics, including Oral administration and Pharmacokinetics.
Microbiology, Clostridium difficile, Antibiotics, Internal medicine and Antibiotic resistance are his primary areas of study. The various areas that he examines in his Microbiology study include Vancomycin, Bacteroides and Virology. His Clostridium difficile research includes elements of Ribotyping, Cadazolid and Metronidazole.
The concepts of his Antibiotics study are interwoven with issues in Microbiome, Avibactam, Dalbavancin and Candida albicans. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Surgery. His study in Antibiotic resistance is interdisciplinary in nature, drawing from both Antibiotic prophylaxis, Propionibacterium acnes and Tigecycline, Antimicrobial, Anti-Infective Agents.
His scientific interests lie mostly in Microbiology, Antibiotic resistance, Clostridium difficile, Drug resistance and Antibiotics. His Microbiology study combines topics from a wide range of disciplines, such as Anaerobic bacteria and Virology. Carl Erik Nord interconnects Internal medicine and Bacteroides in the investigation of issues within Anaerobic bacteria.
His Antibiotic resistance research incorporates themes from Propionibacterium acnes and Tigecycline. The study incorporates disciplines such as Antimicrobial, Intensive care medicine and Metronidazole in addition to Drug resistance. His work investigates the relationship between Antibiotics and topics such as Microbiome that intersect with problems in Metagenomics, Antibiotic prophylaxis and Gut flora.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of antimicrobial agents on the ecological balance of human microflora.
Åsa Sullivan;Charlotta Edlund;Carl Erik Nord.
Lancet Infectious Diseases (2001)
Lack of development of new antimicrobial drugs: a potential serious threat to public health.
S Ragnar Norrby;Carl Erik Nord;Roger Finch.
Lancet Infectious Diseases (2005)
Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
Sonja Löfmark;Charlotta Edlund;Carl Erik Nord.
Clinical Infectious Diseases (2010)
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study
Johan Wiström;S. Ragnar Norrby;Erling B. Myhre;Sverker Eriksson.
Journal of Antimicrobial Chemotherapy (2001)
Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces
Egija Zaura;Bernd W. Brandt;M. Joost Teixeira de Mattos;Mark J. Buijs.
Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria
K. Orrhage;E. Sillerström;Jan-Ake Gustafsson;C. E. Nord.
Mutation Research (1994)
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience
E. Nagy;E. Urbán;Carl Erik Nord.
Clinical Microbiology and Infection (2011)
An Expanded Multilocus Sequence Typing Scheme for Propionibacterium acnes: Investigation of ‘Pathogenic’, ‘Commensal’ and Antibiotic Resistant Strains
Andrew McDowell;Emma Barnard;István Nagy;Anna Gao.
PLOS ONE (2012)
Antimicrobial resistance in Clostridium difficile.
Haihui Huang;Andrej Weintraub;Hong Fang;Carl Erik Nord.
International Journal of Antimicrobial Agents (2009)
Effect of Phenoxymethylpenicillin and Clindamycin on the Oral, Throat and Faecal Microflora of Man
Anders Heimdahl;Carl Erik Nord.
Scandinavian Journal of Infectious Diseases (1979)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: